From genomics to surveillance, prevention and control: New challenges for the African meningitis belt

Epidemiological patterns of the disease in Africa have been changing with the occurrence of outbreaks outside the meningitis belt and with the emergence of serogroup W135. [...]2000, the vast majority of African outbreaks was caused by Neisseria meningitidis serogroup A and could be controlled with...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2006-05, Vol.24 (20), p.4279-4284
Main Authors: Alonso, Jean-Michel, Bertherat, Eric, Perea, William, Borrow, Ray, Chanteau, Suzanne, Cohet, Catherine, Dodet, Betty, Greenwood, Brian, Marc LaForce, F., Rouzic, Erwan Muros-Le, Teyssou, Rémy, Ouedraogo-Traoré, Rasmata, Sow, Idrissa
Format: Article
Language:English
Subjects:
Africa - epidemiology
Anti-Bacterial Agents - therapeutic use
Ceftriaxone - therapeutic use
Chloramphenicol - therapeutic use
Disease Outbreaks
Epidemics
Epidemiology
Genomics
Humans
Meningitis
Meningitis, Meningococcal - diagnosis
Meningitis, Meningococcal - drug therapy
Meningitis, Meningococcal - epidemiology
Meningitis, Meningococcal - genetics
Meningitis, Meningococcal - prevention & control
Molecular Epidemiology
Outbreaks
Population Surveillance
Studies
Vaccines
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Epidemiological patterns of the disease in Africa have been changing with the occurrence of outbreaks outside the meningitis belt and with the emergence of serogroup W135. [...]2000, the vast majority of African outbreaks was caused by Neisseria meningitidis serogroup A and could be controlled with a widely available A/C meningococcal polysaccharide vaccine. A changing epidemiology The conference began by addressing the current situation. Since the late 1980s, many African countries have experienced meningitis epidemics.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2006.03.037